Clofibrate causes an upregulation of PPAR-α target genes but does not alter expression of SREBP target genes in liver and adipose tissue of pigs

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 1, 2007, Pages

  Luci, Sebastian ^a   Giemsa, Beatrice ^a   Kluge, Holger ^a   Eder, Klaus ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cholesterol; Peroxisome proliferator activated receptor ; Triglycerides

Indexed keywords

3 METHYL 3 HYDROXYGLUTARYL COENZYME A REDUCTASE; ACETYL COENZYME A CARBOXYLASE; CLOFIBRATE; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; OXIDOREDUCTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HOMEOSTASIS; INSULIN INDUCED GENE 1; INSULIN INDUCED GENE 2; LIPID METABOLISM; LIPOGENESIS; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SWINE;

3-HYDROXYBUTYRIC ACID; ADIPOSE TISSUE; ANIMALS; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEIN C-III; BODY WEIGHT; CARRIER PROTEINS; CHOLESTEROL; CLOFIBRATE; EATING; LIPOPROTEINS; LIVER; ORGAN SIZE; PPAR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEINS; SWINE; TRIGLYCERIDES; UP-REGULATION;

EID: 34447640129     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00603.2006     Document Type: Article

References (56)

1. Ameen C, Edvardsson U, Ljungberg A, Asp L, Akerblad P, Tuneld A, Olofsson SO, Linden D, Oscarsson J. Activation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liver. J Biol Chem 280: 1224-1229, 2005.
2. Auwerx J, Schoonjans K, Fruchart JC, Staels B. Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects. J Atheroscler Thromb 3: 81-89, 1996.
3. Berthou L, Duverger N, Emmanuel F, Langouet S, Auwerx J, Guillouzo A, Fruchart JC, Rubin E, Denefle P, Staels B, Branellec D. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice. J Clin Invest 97: 2408-2416, 1996.
4. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366, 1996.
5. Bruckert E, Dejager S, Chapman MJ. Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia. Atherosclerosis 100: 91-102, 1993.
6. Carey GB. The swine as a model for studying exercise-induced changes in lipid metabolism. Med Sci Sports Exerc 29: 1437-1443, 1997.
7. Caslake MJ, Packard CJ, Gaw A, Murray E, Griffin BA, Vallance BD, Sheperd J. Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia. Arterioscler Thromb 13: 702-711, 1993.
8. Cheon Y, Nara TY, Band MR, Beever JE, Wallig MA, Nakamura MT. Induction of overlapping genes by fasting and a peroxisome proliferator in pigs: evidence of functional PPAR alpha in nonproliferating species. Am J Physiol Regul Integr Comp Physiol 288: R1525-R1535, 2005.
9. Clavey V, Copin C, Mariotte MC, Bauge E, Chinetti G, Fruchart J, Fruchart JC, Dallongeville J, Staels B. Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells. Cell Physiol Biochem 9: 139-149, 1999.
10. De Hoff JL, Davidson JH, Kritchevsky V. An enzymatic assay for determining free and total cholesterol in tissues. Clin Chem 24: 433-435, 1978.
11. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20: 649-688, 1999.
12. Ding ST, McNeel RL, Mersmann HJ. Expression of porcine adipocyte transcripts: tissue distribution and differentiation in vitro and in vivo. Comp Biochem Physiol B Biochem Mol Biol 123: 307-318, 1999.
13. Ding ST, Schinckel AP, Weber TE, Mersman HJ. Expression of porcine transcription factors and genes related to fatty acid metabolism in different tissues and genetic populations. J Anim Sci 78: 2127-2134, 2000.
14. Frederiksen KS, Wulff EM, Sauerberg P, Mogensen JP, Jeppesen L, Fleckner J. Prediction of PPAR-α ligand-mediated physiological changes using gene expression profiles. J Lipid Res 45: 592-601, 2004.
15. Gandemier G, Pascal G, Durand G. In vivo changes in the rates of total lipid and fatty acid synthesis in liver and white adipose tissues of male rats during postweaning growth. Int J Biochem 14: 797-804, 1982.
16. Gervois P, Toora IP, Fruchart JC, Staels B. Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin Chem Lab Med 38: 3-11, 2000.
17. Guo Q, Wang PR, Milot DP, Ippolito MC, Hernandez M, Burton CA, Wright SD, Chao Y. Regulation of lipid metabolism and gene expression by fenofibrate in hamsters. Biochim Biophys Acta 1533: 220-232, 2001.
18. Hara A, Radin NS. Lipid extraction of tissues with a low toxicity solvent. Anal Biochem 90: 420-426, 1978.
19. Hawkins JM, Jones WE, Bonner FW, Gibson GG. The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab Rev 18: 441-515, 1987.
20. He WS, Nara TY, Nakamura MT. Delayed induction of delta-6 and delta-5 desaturases by a peroxisome proliferators. Biochem Biophys Res Commun 299: 832-838, 2002.
21. Holden PR, Tugwood JD. Peroxisome proliferator-activated receptor α: role in rodent liver cancer and species differences. J Mol Endocrinol 22: 1-8, 1999.
22. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131, 2002.
23. Knight BL, Hebbach A, Hauton D, Brown AM, Wiggins D, Patel DD. A role for PPARα in the control of SREBP activity and lipid synthesis in the liver. Biochem J 389: 413-421, 2005.
24. König B, Eder K. Differential action of 13-HPODE on PPARα downstream genes in rat Fao and human HepG2 hepatoma cell lines. J Nutr Biochem 17: 410-418, 2006.
25. König B, Koch A, Spielmann J, Hilgenfeld C, Stangl GI, Eder K. Activation of PPARα lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2. Biochem Pharmacol 73: 574-585, 2007.
26. Lawrence JW, Li Y, Chen S, DeLuca JG, Berger JP, Umbenhauer DR, Moller DE, Zhou G. Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) α. J Biol Chem 276: 31521-31527, 2001.
27. Lewis GF, Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96: 1221-1232, 2005.
28. Mandard S, Müller M, Kersten S. Peroxisome proliferator-activated receptor α target genes. Cell Mol Life Sci 61: 393-416, 2004.
29. Marrapodi M, Chiang JY. Peroxisome proliferator-activated receptor alpha (PPARα) and agonist inhibit cholesterol 7α-hydroxylase gene (CYP7A1) transcription. J Lipid Res 41: 514-520, 2000.
30. Miller CW, Ntambi JM. Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. Proc Natl Acad Sci USA 93: 9443-9448, 1996.
31. National Research Council. Nutrient Requirement of Swine (10th rev. ed.). Washington, DC: National Academy of Sciences, 1998.
32. Orton TC, Adam HK, Bentley M, Holloway B, Tucker MJ. Clobuzarit: species differences in the morphological and biochemical response of the liver following chronic administration. Toxicol Appl Pharmacol 73: 138-151, 1984.
33. Patel DD, Knight BL, Wiggins D, Humphries SM, Gibbons GF. Disturbances in the normal regulation of SREBP-sensitive genes in PPAR α-deficient mice. J Lipid Res 42: 328-337, 2001.
34. Peffer PL, Lin X, Odle J. Hepatic beta-oxidation and carnitine palmitoyltransferase I in neonatal pigs after dietary treatments of clofibric acid, isoproterenol, and medium-chain triglycerides. Am J Physiol Regul Integr Comp Physiol 288: R1518-R1524, 2005.
35. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294: 169-173, 2001.
36. Peters JM, Cheung C, Gonzalez FJ. Peroxisome proliferator- activated receptor-α and liver cancer: where do we stand? J Mol Med 83: 774-785, 2005.
37. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
38. Post SM, Duez H, Gervois PP, Staels B, Kuipers F, Princen HM. Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-α-mediated downregulation of cholesterol 7α-hydroxylase and sterol 27-hydroxylase expression. Arterioscler Thromb Vasc Biol 21: 1840-1845, 2001.
39. Reinhart GA, Mahan DC, Lepine AJ, Simmen FA, Moore BE. Dietary clofibric acid increases intestinal fatty acid binding protein activity and apparent lipid digestibility in weanling swine. J Anim Sci 71: 2693-2699, 1993.
40. Russell DW. Cholesterol biosynthesis and metabolism. Cardiovasc Drugs Ther 6: 103-110, 1992.
41. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15: 5336-5348, 1996.
42. Schultze AE, Alborn WE, Newton RK, Konrad RJ. Administration of a PPARα agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio. J Lipid Res 46: 1591-1595, 2005.
43. Semenkovich CF, Chen SH, Wims M, Luo CC, Li WH, Chan L. Lipoprotein lipase and hepatic lipase mRNA tissue specific expression, developmental regulation, and evolution. J Lipid Res 30: 423-431, 1989.
44. Semenkovich CF, Coleman T, Fiedorek FT Jr. Human fatty acid synthase mRNA: tissue distribution, genetic mapping, and kinetics of decay after glucose deprivation. J Lipid Res 36: 1507-1521, 1995.
45. Staels B, Auwerx J. Regulation of apo A-I gene expression by fibrates. Atherosclerosis Suppl 137: S19-S23, 1998.
46. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98: 2088-2093, 1998.
47. Staels B, Van Tol A, Andreu T, Auwerx J. Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat. Arterioscler Thromb 12: 179-187, 1992.
48. Stott WT, Yano BL, Williams DM, Barnard SD, Hannah MA, Cieszlak FS, Herman JR. Species-dependent induction of peroxisome proliferation by haloxyfop, an aryloxyphenoxy herbicide. Fundam Appl Toxicol 28: 71-79, 1995.
49. Sundvold H, Grindflek E, Lien S. Tissue distribution of porcine peroxisome proliferator-activated receptor α: detection of an alternatively spliced mRNA. Gene 273: 105-113, 2001.
50. Tugwood JD, Holden PR, James NH, Prince RA, Roberts RA. A peroxisome proliferator-activated receptor-alpha (PPARα) cDNA cloned from guinea-pig liver encodes a protein with similar properties to the mouse PPARα: implications for species differences in responses to peroxisome proliferators. Arch Toxicol 72: 169-177, 1998.
51. Van der Vliet HN, Schaap FG, Levels JH, Ottenhoff R, Looije N, Wesseling JG, Groen AK, Chamuleau RA. Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice. Biochem Biophys Res Commun 295: 1156-1159, 2002.
52. Vu-Dac N, Schoonjans K, Kosykh V, Dallongeville J, Fruchart JC, Staels B, Auwerx J. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J Clin Invest 96: 741-750, 1995.
53. Yabe D, Brown MS, Goldstein JL. Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins. Proc Natl Acad Sci USA 99: 12753-12758, 2002.
54. Yamazaki K, Kuromitsu J, Tanaka I. Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator-activated receptor alpha agonists. Biochem Biophys Res Commun 290: 1114-1122, 2002.
55. Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold R, Goldstein JL, Brown MS. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110: 489-500, 2002.
56. Yu XX, Odle J, Drackley JK. Differential induction of peroxisomal beta-oxidation enzymes by clofibric acid and aspirin in piglet tissues. Am J Physiol Regul Integr Comp Physiol 281: R1553-R1561, 2001.